<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochem Soc Trans</journal-id><journal-id journal-id-type="iso-abbrev">Biochem. Soc. Trans</journal-id><journal-id journal-id-type="hwp">ppbiost</journal-id><journal-id journal-id-type="publisher-id">BST</journal-id><journal-title-group><journal-title>Biochemical Society Transactions</journal-title></journal-title-group><issn pub-type="ppub">0300-5127</issn><issn pub-type="epub">1470-8752</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27911732</article-id><article-id pub-id-type="pmc">5095922</article-id><article-id pub-id-type="publisher-id">BST-2016-0094</article-id><article-id pub-id-type="doi">10.1042/BST20160094</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mitochondria in Health and Disease</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>39</subject><subject>5</subject></subj-group></article-categories><title-group><article-title>The Warburg effect: 80 years on</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Potter</surname><given-names>Michelle</given-names></name></contrib><contrib contrib-type="author"><name><surname>Newport</surname><given-names>Emma</given-names></name></contrib><contrib contrib-type="author"><name><surname>Morten</surname><given-names>Karl J.</given-names></name></contrib></contrib-group><aff>Nuffield Department of Obstetrics and Gynaecology, The Women Centre, University of Oxford, John Radcliffe Hospital, Oxford, U.K.</aff><author-notes><corresp>Correspondence: Karl J. Morten (<email>karl.morten@obs-gyn.ox.ac.uk</email>)</corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2016</year></pub-date><volume>44</volume><issue>5</issue><fpage>1499</fpage><lpage>1505</lpage><history><date date-type="received"><day>1</day><month>4</month><year>2016</year></date><date date-type="rev-recd"><day>29</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>25</day><month>7</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 The Author(s)</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution License 4.0 (CC BY-NC-ND)</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="BST-2016-0094.pdf"/><abstract><p>Influential research by Warburg and Cori in the 1920s ignited interest in how cancer cells' energy generation is different from that of normal cells. They observed high glucose consumption and large amounts of lactate excretion from cancer cells compared with normal cells, which oxidised glucose using mitochondria. It was therefore assumed that cancer cells were generating energy using glycolysis rather than mitochondrial oxidative phosphorylation, and that the mitochondria were dysfunctional. Advances in research techniques since then have shown the mitochondria in cancer cells to be functional across a range of tumour types. However, different tumour populations have different bioenergetic alterations in order to meet their high energy requirement; the Warburg effect is not consistent across all cancer types. This review will discuss the metabolic reprogramming of cancer, possible explanations for the high glucose consumption in cancer cells observed by Warburg, and suggest key experimental practices we should consider when studying the metabolism of cancer.</p></abstract><kwd-group kwd-group-type="author"><kwd>cancer</kwd><kwd>glycolysis</kwd><kwd>mitochondrial respiration</kwd><kwd>Warburg effect</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>The Warburg effect</title><p>Despite decades of research and countless financial investments, cancer continues to elude our complete understanding and more importantly our therapies. Pivotal research in the 1920s by Warburg and Cori demonstrated that cancer avidly consumes glucose and excretes lactate [<xref rid="BST-2016-0094C1" ref-type="bibr">1</xref>,<xref rid="BST-2016-0094C2" ref-type="bibr">2</xref>]. When oxygen is present, normal cells use mitochondria to oxidise glucose, but in the absence of oxygen, glucose is converted into lactate. Otto Warburg first described in the 1920s that cancer cells utilised higher levels of glucose in the presence of oxygen with an associated increase in lactate production. The phenomenon of aerobic glycolysis, termed the Warburg effect, has been observed in a variety of other tumour types, including colorectal cancer [<xref rid="BST-2016-0094C3" ref-type="bibr">3</xref>], breast [<xref rid="BST-2016-0094C4" ref-type="bibr">4</xref>], lung [<xref rid="BST-2016-0094C5" ref-type="bibr">5</xref>] and glioblastoma [<xref rid="BST-2016-0094C6" ref-type="bibr">6</xref>,<xref rid="BST-2016-0094C7" ref-type="bibr">7</xref>]. From his observations, Warburg concluded that the mitochondria were dysfunctional [<xref rid="BST-2016-0094C8" ref-type="bibr">8</xref>,<xref rid="BST-2016-0094C9" ref-type="bibr">9</xref>]. The Warburg effect has been confirmed in previous studies including those of DeBerardinis et al. [<xref rid="BST-2016-0094C10" ref-type="bibr">10</xref>], where cells were incubated under oxygenated conditions in 10&#x02005;mM C-13-labelled glucose. Cells were then perfused using 4&#x02005;mM glucose prior to metabolomics analysis and even in the presence of oxygen, high levels of glycolytic metabolites were observed supporting Warburg's hypothesis. In addition, Fantin et al. [<xref rid="BST-2016-0094C11" ref-type="bibr">11</xref>] made the observation that inhibiting lactate dehydrogenase preventing the conversion of pyruvate to lactate reduced tumourigenicity. These data were interpreted as tumourigenicity being dependent on high levels of energy derived from glycolysis. Another study by Schulz et al. [<xref rid="BST-2016-0094C12" ref-type="bibr">12</xref>] showed that when mitochondrial oxidative phosphorylation is up-regulated by overexpression of frataxin, malignant growth and tumourigenic capacity are decreased. The authors suggest that rather than an increase in glycolysis being the main cause of malignant tumour growth, it is the efficiency of mitochondrial energy conversion that is the key metabolic factor.</p><p>Over the past couple of decades, advances in technology have allowed mitochondrial function to be studied in a far greater detail, and it is now realised that cancer cells have active and functional mitochondria, contrary to Warburg's theory [<xref rid="BST-2016-0094C13" ref-type="bibr">13</xref>,<xref rid="BST-2016-0094C14" ref-type="bibr">14</xref>]. In the last decade, research has shown that different tumour types (and indeed subpopulations within a tumour) have different bioenergetic alterations. This was shown as early as 1967, when Weinhouse reported that slow-growing rat hepatoma cells were oxidative, whereas the more proliferative hepatomas were glycolytic [<xref rid="BST-2016-0094C15" ref-type="bibr">15</xref>]. The Warburg effect is not consistent across all tumours, and the phenomenon of aerobic glycolysis has now been challenged by several groups with many cell lines reported as having mitochondrial function [<xref rid="BST-2016-0094C16" ref-type="bibr">16</xref>&#x02013;<xref rid="BST-2016-0094C18" ref-type="bibr">18</xref>]. In a tumour, it is likely that a dynamic interplay exists between oxidative metabolism and glycolysis. Metabolic flexibility has now been observed in a range of cancers, including cervical, breast and pancreatic cancer (see ref. [<xref rid="BST-2016-0094C16" ref-type="bibr">16</xref>] and reviewed in ref. [<xref rid="BST-2016-0094C19" ref-type="bibr">19</xref>]). In 2004, Zu and Guppy reported that adenosine triphosphate (ATP) derived through glycolysis in various cancers and cell lines accounts for only 17% of the total ATP. In fact, the ATP generated through glycolysis was highly dependent on the cell type and could be as low as 0.31% (fibrosarcoma) or as high as 64% (hepatoma), with the remaining ATP being derived from mitochondrial oxidative phosphorylation [<xref rid="BST-2016-0094C20" ref-type="bibr">20</xref>]. In addition to metabolic flexibility linked to environmental conditions, there is also the influence of various cancer-associated mutations, many of which have an impact on metabolism. Mutations in the mitochondrial tricarboxylic acid cycle and respiratory chain component succinate dehydrogenase, for example, can cause phenochromocytoma and paraganglioma, where neuroendocrine tumours arise in the adrenal medulla and paraganglia in the autonomic nervous system [<xref rid="BST-2016-0094C21" ref-type="bibr">21</xref>,<xref rid="BST-2016-0094C22" ref-type="bibr">22</xref>]. Mutations in isocitrate dehydrogenase 1 are associated with adult cases of glioblastoma and appear to have a major role in the development of the tumour by a gain-of-function effect [<xref rid="BST-2016-0094C23" ref-type="bibr">23</xref>,<xref rid="BST-2016-0094C24" ref-type="bibr">24</xref>]. Understanding how cancer cell environment and mutations affect metabolism will be of fundamental importance in selecting appropriate metabolic drug combinations to impact on patients' cancer cell growth.</p></sec><sec id="s2"><title>Cancer hallmarks and metabolic reprogramming</title><p>Cancer cells show complex, dynamic behaviour allowing survival even in the most unfavourable conditions of substrate and oxygen stress. Advances in technology have helped in furthering our knowledge of the underlying molecular processes underpinning cancer, but there are still many unanswered questions. In 2000, Hanahan and Weinberg published a highly cited review article identifying six cancer hallmarks [<xref rid="BST-2016-0094C25" ref-type="bibr">25</xref>]. These included uncontrolled proliferative signalling, resistance to apoptosis, initiating angiogenesis, acquiring replicative immortality, activating invasion and metastasis and evading growth suppressors. Over the last decade, research has increased our knowledge of cancer, and in 2011, Hanahan and Weinberg extended the list of cancer hallmarks to include metabolic reprogramming/deregulated cellular energetics as an emerging hallmark and potential cancer target [<xref rid="BST-2016-0094C26" ref-type="bibr">26</xref>]. Uncontrolled proliferation is one of the essential characteristics of cancer. It has been proposed that reprogramming energy metabolism is essential to fuel and maintain such behaviour [<xref rid="BST-2016-0094C26" ref-type="bibr">26</xref>]. The exact reasons behind the metabolic switch are not known, but likely reasons include: (i) sustaining high proliferative rates in hypoxia [<xref rid="BST-2016-0094C27" ref-type="bibr">27</xref>] and (ii) evading apoptosis as a result of reduced mitochondrial function [<xref rid="BST-2016-0094C28" ref-type="bibr">28</xref>]. Increases in glycolysis have been linked to invasiveness, with changes in glycolysis identified in several studies [<xref rid="BST-2016-0094C29" ref-type="bibr">29</xref>,<xref rid="BST-2016-0094C30" ref-type="bibr">30</xref>]. However, in all studies listed above, cancer cells were grown on cell culture media containing high levels of glucose between 10 and 25&#x02005;mM. This is considerably higher than plasma glucose, which lies between 4 and 6&#x02005;mM. Levels in a rapidly dividing tumour with poor vasculature are considerably lower. The same is true of studies investigating the role of hypoxia in down-regulating mitochondrial respiration and increasing glycolysis, where 25&#x02005;mM glucose is used in the culture media of key publications [<xref rid="BST-2016-0094C31" ref-type="bibr">31</xref>&#x02013;<xref rid="BST-2016-0094C34" ref-type="bibr">34</xref>]. The impact of high levels of glucose on the above findings is a key consideration for future studies, where it is crucial to test new drugs targeting cancer cell metabolism under physiologically relevant conditions. Metformin, for example, a drug currently being investigated as an anticancer agent in a wide range of cancers [<xref rid="BST-2016-0094C35" ref-type="bibr">35</xref>], has recently been shown to be more effective in enhancing chemotherapy sensitivity of oesophageal squamous cancer cells under reduced glucose conditions [<xref rid="BST-2016-0094C36" ref-type="bibr">36</xref>]. Although its mode of action on cancer cells <italic>in vivo</italic> is not entirely clear, mitochondrial studies suggest that metformin can directly impair complex I of the respiratory chain [<xref rid="BST-2016-0094C37" ref-type="bibr">37</xref>,<xref rid="BST-2016-0094C38" ref-type="bibr">38</xref>]. The effect observed by Yu et al. is probably due to a greater reliance of the cancer cells on mitochondrial respiration for energy production when cultured on reduced glucose conditions. Previous studies have shown that high levels of glucose in the culture media can significantly reduce levels of mitochondrial respiration, with reduced glucose conditions showing much higher rates of mitochondrial respiration, as cells use other substrates for cellular ATP production [<xref rid="BST-2016-0094C39" ref-type="bibr">39</xref>,<xref rid="BST-2016-0094C40" ref-type="bibr">40</xref>]. Similar results are shown in <xref rid="BST-2016-0094F1" ref-type="fig">Figure 1</xref>, where the oxygen consumption rates (OCRs; mitochondrial respiration) and extracellular acidification rates (ECAR; glycolysis) of a range of cancer cell lines are compared under high (25&#x02005;mM) and low (1&#x02005;mM) glucose conditions. Under high glucose (25&#x02005;mM) conditions, cancer cell lines either show the Warburg effect (low OCR and high ECAR), high rates of OCR and low ECAR or something in between high/moderate OCR with high/moderate ECAR. A finding highly relevant to the situation <italic>in vivo</italic> is that when cultured under low glucose (1&#x02005;mM) conditions, all cancer lines tested show high&#x02013;moderate OCR with very little ECAR (glycolysis).
<fig id="BST-2016-0094F1" orientation="portrait" position="float"><label>Figure&#x000a0;1.</label><caption><title>Bioenergetic profiles of cancer cell lines RD, RH30, U87MG, M059K, SF188, KNS42, UW479 and Res259.</title><p>OCR and ECAR are plotted to quantify mitochondrial respiration and to give an indication of glycolysis rates. OCR and ECAR are expressed as changes in fluorescence life time/h/75&#x02009;000 cells (<italic>n</italic>&#x02009;=&#x02009;3). Assays were set up in black 96-well plates with pre-incubation in 1&#x02005;mM and 25&#x02005;mM glucose media carried out for 16&#x02005;h. Oxygen and glycolysis sensing probes: MitoXpress xtra and pH xtra from Luxcel Biosciences were used to determine OCR and ECAR (<ext-link ext-link-type="uri" xlink:href="http://luxcel.com/">http://luxcel.com/</ext-link>).</p></caption><graphic xlink:href="BST-2016-0094.01"/></fig></p></sec><sec id="s3"><title>Positron emission tomography imaging and the reverse Warburg effect</title><p>Positron emission tomography (PET) imaging uses a radioisotope-labelled glucose tracer, <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG), to identify areas of high glucose uptake/metabolism in the body. <sup>18</sup>F-FDG is transported into cells by glucose transporters (GLUTs) and phosphorylated by hexokinase (HK) to <sup>18</sup>F-FDG-6-phosphate (<sup>18</sup>F-FDG-6-P). Once inside the cell, <sup>18</sup>F-FDG-6-P cannot be further metabolised through the glycolytic pathway and due to its high polar nature becomes trapped. Tumours above a certain size label strongly with this approach, and it is used to identify the presence of solid tumours and the effectiveness of treatments. Other highly metabolically active tissues, such as the brain and heart, also label strongly. It is believed that PET scans show an increased uptake of glucose in tumours due to overexpression of GLUTs [<xref rid="BST-2016-0094C41" ref-type="bibr">41</xref>&#x02013;<xref rid="BST-2016-0094C43" ref-type="bibr">43</xref>]. Historically, increased glucose uptake has been associated with supporting the Warburg effect [<xref rid="BST-2016-0094C20" ref-type="bibr">20</xref>]. However, high glucose uptake does not automatically equate to increased glycolysis and reduced mitochondrial metabolism. An increased PET signal could be due to a general increase in glucose oxidation with increased glycolysis and mitochondrial respiration or a high demand for lipids derived from glucose. In addition, overexpression of GLUTs cannot be assumed to correlate with increased metabolic flux. A high PET signal would be obtained if glucose entered the cancer cell and was not metabolised. Many tumours are characterised by increased levels of GLUTs (particularly GLUT 1 and GLUT 3) and high expression of HK (I and II), which is associated with the increases in <sup>18</sup>F-FDG signal compared with surrounding tissues as reviewed in ref. [<xref rid="BST-2016-0094C44" ref-type="bibr">44</xref>]. However, not all cancers are easily detected by PET imaging, including renal clear cell carcinoma, which is a prototypical Warburg cancer [<xref rid="BST-2016-0094C45" ref-type="bibr">45</xref>]. Conversely, not all <sup>18</sup>F-FDG avid tissue is malignant; inflammation can also lead to a positive PET signal. Interestingly, Hodgkin's lymphoma responds well to PET imaging [<xref rid="BST-2016-0094C46" ref-type="bibr">46</xref>]. This tumour is less than 10% cancer cells, and the remaining cells are stromal/inflammation cells [<xref rid="BST-2016-0094C47" ref-type="bibr">47</xref>].</p><p>Although PET imaging is undeniably an extremely useful and an important clinical technique, there can be issues with the interpretation of the image. It is a common problem that the PET images can often overestimate the actual size of the tumour. A possible reason for this is that the microenvironment of the tumour is glycolytic in a phenomenon that has been called the reverse Warburg effect. First postulated by Pavlides et al. in 2009 [<xref rid="BST-2016-0094C48" ref-type="bibr">48</xref>], the reverse Warburg effect describes how oxidative stress in the cancer-associated fibroblasts (CAF) induces mitophagy and autophagy. The hypothesis is that hydrogen peroxide secreted from the cancer cells leads to oxidative stress in the CAF. The fibroblasts then undergo cellular catabolism, which results in a loss of mitochondrial function and ultimately a switch from aerobic metabolism to glycolysis [<xref rid="BST-2016-0094C49" ref-type="bibr">49</xref>]. This glycolytic switch results in increased lactate production by CAF, which is then exported into the extracellular space by monocarboxylate transporter 4 (MCT4). The lactate is ultimately taken up by the cancer cells via MCT1 and used to fuel oxidative metabolism [<xref rid="BST-2016-0094C50" ref-type="bibr">50</xref>,<xref rid="BST-2016-0094C51" ref-type="bibr">51</xref>]. In ref. [<xref rid="BST-2016-0094C50" ref-type="bibr">50</xref>], the authors demonstrate support for the reverse Warburg effect by culturing human breast cancer cell lines with human fibroblasts. Both MCF-7 and MDA-MB-231, when co-cultured with fibroblasts, show reduced mitochondrial function in fibroblasts with increased activity in the cancer cell lines. As in the studies of the Warburg effect and the impact of hypoxia described earlier, studies to date on the reverse Warburg effect use high concentrations of glucose 25&#x02005;mM. If glucose is rapidly removed from the media by the cancer cells, this would tend to drive the cancer cells to use mitochondrial respiration (see <xref rid="BST-2016-0094F1" ref-type="fig">Figure 1</xref>). Under high glucose conditions, this property of cancer cell lines will be held back by glucose inhibition of mitochondrial respiration.</p><p>Lactate was discovered in the late 1700s and was traditionally thought of as a waste product of glycolysis. In reality, lactate is an extremely efficient fuel and also an important signalling molecule [<xref rid="BST-2016-0094C52" ref-type="bibr">52</xref>,<xref rid="BST-2016-0094C53" ref-type="bibr">53</xref>]. It is constantly turned around in our cells, regardless of oxygenation state. Lactate is a key metabolite in the body, capable of replacing glucose as an energy source. Lactate is also capable of stabilising hypoxia-inducing factor and increasing vascular endothelial growth factor expression [<xref rid="BST-2016-0094C53" ref-type="bibr">53</xref>]. The fibroblast&#x02013;tumour metabolic coupling proposed to exist in the reverse Warburg effect is analogous to the metabolic symbiosis seen in the brain (<xref rid="BST-2016-0094F2" ref-type="fig">Figure 2</xref>). The brain is a metabolically demanding organ that gives high PET signals. Its avidity for glucose was historically attributed to the neurons; however, it is the astrocytes that are glucose hungry and glycolytic. The lactate secreted by the astrocytes then fuels the neurons, which use oxidative phosphorylation to generate ATP [<xref rid="BST-2016-0094C54" ref-type="bibr">54</xref>]. The Warburg effect is not a universal feature of cancer, and similarly the reverse Warburg is not universal in all tumours. Yoshida, in 2015, showed that tumours expressing high levels of MCT4 do no exhibit the reverse Warburg effect [<xref rid="BST-2016-0094C55" ref-type="bibr">55</xref>]. The microenvironment of cancer is ever changing, and cancer cells can and do vary in their metabolic phenotype even within the same tumour mass [<xref rid="BST-2016-0094C56" ref-type="bibr">56</xref>]. Although hard to generalise in solid tumours with a hypoxic core, perhaps the Warburg effect most probably predominates with reduced oxygen levels driving the cells to make the most of all available glucose. The more actively proliferating cells in the periphery may perhaps use the lactate excreted in the hypoxic region and oxidise it [<xref rid="BST-2016-0094C57" ref-type="bibr">57</xref>], leading to a symbiotic relationship between the hypoxic and aerobic cell populations. <italic>In vitro</italic> metabolism studies are useful tools, but it only serves to hinder therapeutic translation when non-physiological glucose concentrations up to and including 25&#x02005;mM glucose are used instead of a physiological concentration of 5&#x02005;mM (plasma) or &#x0003c;5&#x02005;mM (tissue).
<fig id="BST-2016-0094F2" orientation="portrait" position="float"><label>Figure&#x000a0;2.</label><caption><title>The astrocyte&#x02013;neuron shuttle (A) and the reverse Warburg effect (B).</title><p>(<bold>A</bold>) Glutamate is released from activated synapses and taken up by astrocytes triggering an increase in glycolysis and lactate production. The lactate can be oxidised by the neurons in response to their increased energy requirement to produce ATP. (<bold>B</bold>) nIn the proposed reverse Warburg effect, hydrogen peroxide is secreted by cancer cells leading to oxidative stress in the associated fibroblasts. The resulting loss of mitochondrial function acts as a switch from aerobic metabolism to glycolysis.</p></caption><graphic xlink:href="BST-2016-0094.02"/></fig></p><p>In summary, we have sought here to revisit the Warburg effect and review its significance in cancer based on recent advances in our knowledge and understanding of the complex biology underlying this disease. It is indisputable that certain features of cancer are indeed hallmarks that are essential for most types of cancer. However, looking to the future, the role of aerobic glycolysis needs further elucidation, as it is not a consistent feature in all cancers. Recent research has shown there to be a broad spectrum of bioenergetic phenotypes displayed by cancer both <italic>in vivo</italic> and <italic>in vitro</italic>, with many cancer types displaying a surprising degree of mitochondrial activity. When investigating the role of aerobic glycolysis <italic>in vitro</italic>, it is pertinent to use physiologically relevant concentrations of nutrients, in particular glucose. The excessive glucose often found in cell culture media can decrease mitochondrial respiration, allowing aerobic glycolysis to predominate. Reducing the glucose in the media to physiological levels will give a truer picture of the complex metabolic processes at work.</p></sec><sec id="s4"><title>Abbreviations</title><p><sup>18</sup>F-FDG, <sup>18</sup>F-fluorodeoxyglucose; <sup>18</sup>F-FDG-6-P, <sup>18</sup>F-FDG-6-phosphate; ATP, adenosine triphosphate; CAF, cancer-associated fibroblasts; ECAR, extracellular acidification rate; GLUT, glucose transporter; HK, hexokinase; MCT4, monocarboxylate transporter 4; OCR, oxygen consumption rate; PET, positron emission tomography.</p></sec><sec id="s5"><title>Funding</title><p>Michelle Potter and Emma Newport were supported by Williams fund (<ext-link ext-link-type="uri" xlink:href="http://www.williamsfund.co.uk/">http://www.williamsfund.co.uk/</ext-link>).</p></sec><sec id="s6"><title>Competing Interests</title><p>The Authors declare that there are no competing interests associated with the manuscript.</p></sec></body><back><ref-list><title>References</title><ref id="BST-2016-0094C1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warburg</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Wind</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Negelein</surname><given-names>E.</given-names></name></person-group> (<year>1927</year>) <article-title>The metabolism of tumors in the body</article-title>. <source>J. Gen. Physiol.</source>
<volume>8</volume>, <fpage>519</fpage>&#x02013;<lpage>530</lpage> doi:<pub-id pub-id-type="doi">10.1085/jgp.8.6.519</pub-id><pub-id pub-id-type="pmid">19872213</pub-id></mixed-citation></ref><ref id="BST-2016-0094C2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cori</surname><given-names>C.A.</given-names></name> and <name name-style="western"><surname>Cori</surname><given-names>G.T.</given-names></name></person-group> (<year>1925</year>) <article-title>The carbohydrate metabolism of tumours</article-title>. <source>J. Biol. Chem.</source>
<volume>65</volume>, <fpage>397</fpage>&#x02013;<lpage>405</lpage></mixed-citation></ref><ref id="BST-2016-0094C3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakashita</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Aoyama,</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Maekawa</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kuroda</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shirasaka</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>) <article-title>Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features</article-title>. <source>Eur. J. Cancer</source>
<volume>37</volume>, <fpage>204</fpage>&#x02013;<lpage>209</lpage> doi:<pub-id pub-id-type="doi">10.1016/S0959-8049(00)00371-3</pub-id><pub-id pub-id-type="pmid">11166147</pub-id></mixed-citation></ref><ref id="BST-2016-0094C4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grover-McKay</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Seftor</surname><given-names>E.A.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>P.A.</given-names></name> and <name name-style="western"><surname>Hendrix</surname><given-names>M.J.C.</given-names></name></person-group> (<year>1998</year>) <article-title>Role for glucose transporter 1 protein in human breast cancer</article-title>. <source>Pathol. Oncol. Res.</source>
<volume>4</volume>, <fpage>115</fpage>&#x02013;<lpage>120</lpage> doi:<pub-id pub-id-type="doi">10.1007/BF02904704</pub-id><pub-id pub-id-type="pmid">9654596</pub-id></mixed-citation></ref><ref id="BST-2016-0094C5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Neilson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Swift</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Moran</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tamagnine</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Parslow</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2007</year>) <article-title>Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells</article-title>. <source>Am. J. Physiol. Cell Physiol.</source>
<volume>292</volume>, <fpage>C125</fpage>&#x02013;<lpage>C136</lpage> doi:<pub-id pub-id-type="doi">10.1152/ajpcell.00247.2006</pub-id><pub-id pub-id-type="pmid">16971499</pub-id></mixed-citation></ref><ref id="BST-2016-0094C6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>J.-H.</given-names></name>, <name name-style="western"><surname>Jan</surname><given-names>H.-J.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L.-W.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C.-C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.-G.</given-names></name>, <name name-style="western"><surname>Hueng</surname><given-names>D.-Y.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>) <article-title>Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1&#x003b1;</article-title>. <source>Neuro-Oncology</source>
<volume>15</volume>, <fpage>1330</fpage>&#x02013;<lpage>1341</lpage> doi:<pub-id pub-id-type="doi">10.1093/neuonc/not086</pub-id><pub-id pub-id-type="pmid">23911596</pub-id></mixed-citation></ref><ref id="BST-2016-0094C7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michelakis</surname><given-names>E.D.</given-names></name>, <name name-style="western"><surname>Sutendra</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Dromparis</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Webster</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Haromy</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Niven</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>) <article-title>Metabolic modulation of glioblastoma with dichloroacetate</article-title>. <source>Sci. Transl. Med.</source>
<volume>2</volume>, <fpage>31ra34</fpage> doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3000677</pub-id></mixed-citation></ref><ref id="BST-2016-0094C8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warburg</surname><given-names>O.</given-names></name></person-group> (<year>1956</year>) <article-title>On the origin of cancer cells</article-title>. <source>Science</source>
<volume>123</volume>, <fpage>309</fpage>&#x02013;<lpage>314</lpage> doi:<pub-id pub-id-type="doi">10.1126/science.123.3191.309</pub-id><pub-id pub-id-type="pmid">13298683</pub-id></mixed-citation></ref><ref id="BST-2016-0094C9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warburg</surname><given-names>O.</given-names></name></person-group> (<year>1956</year>) <article-title>On respiratory impairment in cancer cells</article-title>. <source>Science</source>
<volume>124</volume>, <fpage>269</fpage>&#x02013;<lpage>270</lpage> PMID: <pub-id pub-id-type="pmid">13351639</pub-id></mixed-citation></ref><ref id="BST-2016-0094C10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeBerardinis</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Mancuso</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Daikhin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Nissim</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Yudkoff</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wehrli</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2007</year>) <article-title>Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>104</volume>, <fpage>19345</fpage>&#x02013;<lpage>19350</lpage> doi:<pub-id pub-id-type="doi">10.1073/pnas.0709747104</pub-id><pub-id pub-id-type="pmid">18032601</pub-id></mixed-citation></ref><ref id="BST-2016-0094C11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fantin</surname><given-names>V.R.</given-names></name>, <name name-style="western"><surname>St-Pierre</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Leder</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>) <article-title>Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance</article-title>. <source>Cancer Cell</source>
<volume>9</volume>, <fpage>425</fpage>&#x02013;<lpage>434</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.ccr.2006.04.023</pub-id><pub-id pub-id-type="pmid">16766262</pub-id></mixed-citation></ref><ref id="BST-2016-0094C12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Thierbach</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Voigt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Drewes</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mietzner</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Steinberg</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2006</year>) <article-title>Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: OTTO WARBURG REVISITED</article-title>. <source>J. Biol. Chem.</source>
<volume>281</volume>, <fpage>977</fpage>&#x02013;<lpage>981</lpage> doi:<pub-id pub-id-type="doi">10.1074/jbc.M511064200</pub-id><pub-id pub-id-type="pmid">16263703</pub-id></mixed-citation></ref><ref id="BST-2016-0094C13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ju</surname><given-names>Y.S.</given-names></name>, <name name-style="western"><surname>Alexandrov</surname><given-names>L.B.</given-names></name>, <name name-style="western"><surname>Gerstung</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Martincorena</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Nik-Zainal</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ramakrishna</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>) <article-title>Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer</article-title>. <source>eLife</source>
<volume>3</volume>, <fpage>e02935</fpage> doi:<pub-id pub-id-type="doi">10.7554/eLife.02935</pub-id></mixed-citation></ref><ref id="BST-2016-0094C14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X.D.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>S.X.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>H.P.</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>Y.W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.C.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Warburg effect or reverse Warburg effect? A review of cancer metabolism</article-title>. <source>Oncol. Res. Treat.</source>
<volume>38</volume>, <fpage>117</fpage>&#x02013;<lpage>122</lpage> doi:<pub-id pub-id-type="doi">10.1159/000375435</pub-id><pub-id pub-id-type="pmid">25792083</pub-id></mixed-citation></ref><ref id="BST-2016-0094C15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinhouse</surname><given-names>S.</given-names></name></person-group> (<year>1967</year>) <article-title>Hepatomas</article-title>. <source>Science</source>
<volume>158</volume>, <fpage>542</fpage>&#x02013;<lpage>545</lpage> doi:<pub-id pub-id-type="doi">10.1126/science.158.3800.542</pub-id><pub-id pub-id-type="pmid">4293299</pub-id></mixed-citation></ref><ref id="BST-2016-0094C16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jose</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bellance</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Rossignol</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>) <article-title>Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?</article-title>
<source>Biochim. Biophys. Acta, Bioenerg.</source>
<volume>1807</volume>, <fpage>552</fpage>&#x02013;<lpage>561</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.bbabio.2010.10.012</pub-id></mixed-citation></ref><ref id="BST-2016-0094C17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno-S&#x000e1;nchez</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rodr&#x000ed;guez-Enr&#x000ed;quez</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mar&#x000ed;n-Hern&#x000e1;ndez</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Saavedra</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>) <article-title>Energy metabolism in tumor cells</article-title>. <source>FEBS J.</source>
<volume>274</volume>, <fpage>1393</fpage>&#x02013;<lpage>1418</lpage> doi:<pub-id pub-id-type="doi">10.1111/j.1742-4658.2007.05686.x</pub-id><pub-id pub-id-type="pmid">17302740</pub-id></mixed-citation></ref><ref id="BST-2016-0094C18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Beauvoit</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Voisin</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>Canioni</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Gu&#x000e9;rin</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Rigoulet</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>) <article-title>Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation</article-title>. <source>J. Bioenerg. Biomembr.</source>
<volume>30</volume>, <fpage>565</fpage>&#x02013;<lpage>578</lpage> doi:<pub-id pub-id-type="doi">10.1023/A:1020584517588</pub-id><pub-id pub-id-type="pmid">10206476</pub-id></mixed-citation></ref><ref id="BST-2016-0094C19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obre</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Rossignol</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>) <article-title>Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy</article-title>. <source>Int. J. Biochem. Cell Biol.</source>
<volume>59</volume>, <fpage>167</fpage>&#x02013;<lpage>181</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.biocel.2014.12.008</pub-id><pub-id pub-id-type="pmid">25542180</pub-id></mixed-citation></ref><ref id="BST-2016-0094C20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zu</surname><given-names>X.L.</given-names></name> and <name name-style="western"><surname>Guppy</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>) <article-title>Cancer metabolism: facts, fantasy, and fiction</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>313</volume>, <fpage>459</fpage>&#x02013;<lpage>465</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.bbrc.2003.11.136</pub-id><pub-id pub-id-type="pmid">14697210</pub-id></mixed-citation></ref><ref id="BST-2016-0094C21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Astuti</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Latif</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Dallol</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dahia</surname><given-names>P.L.M.</given-names></name>, <name name-style="western"><surname>Douglas</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>George</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>) <article-title>Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma</article-title>. <source>Am. J. Hum. Genet.</source>
<volume>69</volume>, <fpage>49</fpage>&#x02013;<lpage>54</lpage> doi:<pub-id pub-id-type="doi">10.1086/321282</pub-id><pub-id pub-id-type="pmid">11404820</pub-id></mixed-citation></ref><ref id="BST-2016-0094C22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baysal</surname><given-names>B.E.</given-names></name>, <name name-style="western"><surname>Ferrell</surname><given-names>R.E.</given-names></name>, <name name-style="western"><surname>Willett-Brozick</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>E.C.</given-names></name>, <name name-style="western"><surname>Myssiorek</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bosch</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2000</year>) <article-title>Mutations in <italic>SDHD</italic>, a mitochondrial complex II gene, in hereditary paraganglioma</article-title>. <source>Science</source>
<volume>287</volume>, <fpage>848</fpage>&#x02013;<lpage>851</lpage> doi:<pub-id pub-id-type="doi">10.1126/science.287.5454.848</pub-id><pub-id pub-id-type="pmid">10657297</pub-id></mixed-citation></ref><ref id="BST-2016-0094C23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>B.D.</given-names></name>, <name name-style="western"><surname>Bittinger</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Driggers</surname><given-names>E.M.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>) <article-title>Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</article-title>. <source>Nature</source>
<volume>462</volume>, <fpage>739</fpage>&#x02013;<lpage>744</lpage> doi:<pub-id pub-id-type="doi">10.1038/nature08617</pub-id><pub-id pub-id-type="pmid">19935646</pub-id></mixed-citation></ref><ref id="BST-2016-0094C24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bigner</surname><given-names>D.D.</given-names></name>, <name name-style="western"><surname>Velculescu</surname><given-names>V.</given-names></name> and <name name-style="western"><surname>Parsons</surname><given-names>D.W.</given-names></name></person-group> (<year>2009</year>) <article-title>Mutant metabolic enzymes are at the origin of gliomas</article-title>. <source>Cancer Res.</source>
<volume>69</volume>, <fpage>9157</fpage>&#x02013;<lpage>9159</lpage> doi:<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-2650</pub-id><pub-id pub-id-type="pmid">19996293</pub-id></mixed-citation></ref><ref id="BST-2016-0094C25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanahan</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group> (<year>2000</year>) <article-title>The hallmarks of cancer</article-title>. <source>Cell</source>
<volume>100</volume>, <fpage>57</fpage>&#x02013;<lpage>70</lpage> doi:<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81683-9</pub-id><pub-id pub-id-type="pmid">10647931</pub-id></mixed-citation></ref><ref id="BST-2016-0094C26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanahan</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group> (<year>2011</year>) <article-title>Hallmarks of cancer: the next generation</article-title>. <source>Cell</source>
<volume>144</volume>, <fpage>646</fpage>&#x02013;<lpage>674</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></mixed-citation></ref><ref id="BST-2016-0094C27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gatenby</surname><given-names>R.A.</given-names></name> and <name name-style="western"><surname>Gillies</surname><given-names>R.J.</given-names></name></person-group> (<year>2004</year>) <article-title>Why do cancers have high aerobic glycolysis?</article-title>
<source>Nat. Rev. Cancer</source>
<volume>4</volume>, <fpage>891</fpage>&#x02013;<lpage>899</lpage> doi:<pub-id pub-id-type="doi">10.1038/nrc1478</pub-id><pub-id pub-id-type="pmid">15516961</pub-id></mixed-citation></ref><ref id="BST-2016-0094C28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gogvadze</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Orrenius</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Zhivotovsky</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>) <article-title>Mitochondria in cancer cells: what is so special about them?</article-title>
<source>Trends Cell Biol.</source>
<volume>18</volume>, <fpage>165</fpage>&#x02013;<lpage>173</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.tcb.2008.01.006</pub-id><pub-id pub-id-type="pmid">18296052</pub-id></mixed-citation></ref><ref id="BST-2016-0094C29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinhouse</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shatton</surname><given-names>J.B.</given-names></name>, <name name-style="western"><surname>Criss</surname><given-names>W.E.</given-names></name> and <name name-style="western"><surname>Morris</surname><given-names>H.P.</given-names></name></person-group> (<year>1972</year>) <article-title>Molecular forms of enzymes in cancer</article-title>. <source>Biochimie</source>
<volume>54</volume>, <fpage>685</fpage>&#x02013;<lpage>693</lpage> doi:<pub-id pub-id-type="doi">10.1016/S0300-9084(72)80167-6</pub-id><pub-id pub-id-type="pmid">4347395</pub-id></mixed-citation></ref><ref id="BST-2016-0094C30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bettum</surname><given-names>I.J.</given-names></name>, <name name-style="western"><surname>Gorad</surname><given-names>S.S.</given-names></name>, <name name-style="western"><surname>Barkovskaya</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pettersen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Moestue</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Vasiliauskaite</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>) <article-title>Metabolic reprogramming supports the invasive phenotype in malignant melanoma</article-title>. <source>Cancer Lett.</source>
<volume>366</volume>, <fpage>71</fpage>&#x02013;<lpage>83</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.canlet.2015.06.006</pub-id><pub-id pub-id-type="pmid">26095603</pub-id></mixed-citation></ref><ref id="BST-2016-0094C31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iyer</surname><given-names>N.V.</given-names></name>, <name name-style="western"><surname>Kotch</surname><given-names>L.E.</given-names></name>, <name name-style="western"><surname>Agani</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Laughner</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wenger</surname><given-names>R.H.</given-names></name><etal>et al.</etal></person-group> (<year>1998</year>) <article-title>Cellular and developmental control of O<sub>2</sub> homeostasis by hypoxia-inducible factor 1&#x003b1;</article-title>. <source>Genes Dev.</source>
<volume>12</volume>, <fpage>149</fpage>&#x02013;<lpage>162</lpage> doi:<pub-id pub-id-type="doi">10.1101/gad.12.2.149</pub-id><pub-id pub-id-type="pmid">9436976</pub-id></mixed-citation></ref><ref id="BST-2016-0094C32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.-w.</given-names></name>, <name name-style="western"><surname>Tchernyshyov</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Semenza</surname><given-names>G.L.</given-names></name> and <name name-style="western"><surname>Dang</surname><given-names>C.V.</given-names></name></person-group> (<year>2006</year>) <article-title>HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</article-title>. <source>Cell Metab.</source>
<volume>3</volume>, <fpage>177</fpage>&#x02013;<lpage>185</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2006.02.002</pub-id><pub-id pub-id-type="pmid">16517405</pub-id></mixed-citation></ref><ref id="BST-2016-0094C33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papandreou</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Cairns</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Fontana</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>A.L.</given-names></name> and <name name-style="western"><surname>Denko</surname><given-names>N.C.</given-names></name></person-group> (<year>2006</year>) <article-title>HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption</article-title>. <source>Cell Metab.</source>
<volume>3</volume>, <fpage>187</fpage>&#x02013;<lpage>197</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2006.01.012</pub-id><pub-id pub-id-type="pmid">16517406</pub-id></mixed-citation></ref><ref id="BST-2016-0094C34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seagroves</surname><given-names>T.N.</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>H.E.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wouters</surname><given-names>B.G.</given-names></name>, <name name-style="western"><surname>Knapp</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Thibault</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>) <article-title>Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells</article-title>. <source>Mol. Cell. Biol.</source>
<volume>21</volume>, <fpage>3436</fpage>&#x02013;<lpage>3444</lpage> doi:<pub-id pub-id-type="doi">10.1128/MCB.21.10.3436-3444.2001</pub-id><pub-id pub-id-type="pmid">11313469</pub-id></mixed-citation></ref><ref id="BST-2016-0094C35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinn</surname><given-names>B.J.</given-names></name>, <name name-style="western"><surname>Kitagawa</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Memmott</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Gills</surname><given-names>J.J.</given-names></name> and <name name-style="western"><surname>Dennis</surname><given-names>P.A.</given-names></name></person-group> (<year>2013</year>) <article-title>Repositioning metformin for cancer prevention and treatment</article-title>. <source>Trends Endocrinol. Metab.</source>
<volume>24</volume>, <fpage>469</fpage>&#x02013;<lpage>480</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.tem.2013.05.004</pub-id><pub-id pub-id-type="pmid">23773243</pub-id></mixed-citation></ref><ref id="BST-2016-0094C36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bian</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>He</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>) <article-title>Metformin synergistically enhances cisplatin-induced cytotoxicity in esophageal squamous cancer cells under glucose-deprivation conditions</article-title>. <source>Biomed. Res. Int.</source>
<volume>2016</volume>, <fpage>8</fpage> doi:<pub-id pub-id-type="doi">10.1155/2016/8678634</pub-id></mixed-citation></ref><ref id="BST-2016-0094C37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Mir</surname><given-names>M.-Y.</given-names></name>, <name name-style="western"><surname>Nogueira</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Fontaine</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Averet</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Rigoulet</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Leverve</surname><given-names>X.</given-names></name></person-group> (<year>2000</year>) <article-title>Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I</article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume>, <fpage>223</fpage>&#x02013;<lpage>228</lpage> doi:<pub-id pub-id-type="doi">10.1074/jbc.275.1.223</pub-id><pub-id pub-id-type="pmid">10617608</pub-id></mixed-citation></ref><ref id="BST-2016-0094C38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Owen</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Doran</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Halestrap</surname><given-names>A.P.</given-names></name></person-group> (<year>2000</year>) <article-title>Evidence that metformin exerts its anti-diabetic effects through inhibition of complex&#x02009;1 of the mitochondrial respiratory chain</article-title>. <source>Biochem. J.</source>
<volume>348</volume>, <fpage>607</fpage>&#x02013;<lpage>614</lpage> doi:<pub-id pub-id-type="doi">10.1042/bj3480607</pub-id><pub-id pub-id-type="pmid">10839993</pub-id></mixed-citation></ref><ref id="BST-2016-0094C39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gohil</surname><given-names>V.M.</given-names></name>, <name name-style="western"><surname>Sheth</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Nilsson</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wojtovich</surname><given-names>A.P.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Perocchi</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>) <article-title>Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis</article-title>. <source>Nat. Biotechnol.</source>
<volume>28</volume>, <fpage>249</fpage>&#x02013;<lpage>255</lpage> doi:<pub-id pub-id-type="doi">10.1038/nbt.1606</pub-id><pub-id pub-id-type="pmid">20160716</pub-id></mixed-citation></ref><ref id="BST-2016-0094C40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marroquin</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Hynes</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dykens</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Jamieson</surname><given-names>J.D.</given-names></name> and <name name-style="western"><surname>Will</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>) <article-title>Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants</article-title>. <source>Toxicol. Sci.</source>
<volume>97</volume>, <fpage>539</fpage>&#x02013;<lpage>547</lpage> doi:<pub-id pub-id-type="doi">10.1093/toxsci/kfm052</pub-id><pub-id pub-id-type="pmid">17361016</pub-id></mixed-citation></ref><ref id="BST-2016-0094C41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S.G.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>W.A.</given-names></name> and <name name-style="western"><surname>Han</surname><given-names>K.M.</given-names></name></person-group> (<year>2012</year>) <article-title>Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma</article-title>. <source>Nucl. Med. Biol.</source>
<volume>39</volume>, <fpage>1167</fpage>&#x02013;<lpage>1172</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.nucmedbio.2012.07.003</pub-id><pub-id pub-id-type="pmid">22901702</pub-id></mixed-citation></ref><ref id="BST-2016-0094C42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riedl</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Brader</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zanzonico</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Woo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>) <article-title>Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic <sup>18</sup>F-MISO and <sup>124</sup>I-IAZG PET in the same study cohort</article-title>. <source>Eur. J. Nucl. Med. Mol. Imaging</source>
<volume>35</volume>, <fpage>39</fpage>&#x02013;<lpage>46</lpage> doi:<pub-id pub-id-type="doi">10.1007/s00259-007-0522-2</pub-id><pub-id pub-id-type="pmid">17786438</pub-id></mixed-citation></ref><ref id="BST-2016-0094C43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>T.C.</given-names></name>, <name name-style="western"><surname>See</surname><given-names>L.C.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>C.H.</given-names></name>, <name name-style="western"><surname>Yah-Huei</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>K.K.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>S.Y.</given-names></name>, <etal>et al.</etal></person-group> (<year>2004</year>) <article-title><sup>18</sup>F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression</article-title>. <source>J. Nucl. Med.</source>
<volume>45</volume>, <fpage>22</fpage>&#x02013;<lpage>29</lpage> PMID: <pub-id pub-id-type="pmid">14734665</pub-id></mixed-citation></ref><ref id="BST-2016-0094C44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barron</surname><given-names>C.C.</given-names></name>, <name name-style="western"><surname>Bilan</surname><given-names>P.J.</given-names></name>, <name name-style="western"><surname>Tsakiridis</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Tsiani</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>) <article-title>Facilitative glucose transporters: implications for cancer detection, prognosis and treatment</article-title>. <source>Metabolism</source>
<volume>65</volume>, <fpage>124</fpage>&#x02013;<lpage>139</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.metabol.2015.10.007</pub-id><pub-id pub-id-type="pmid">26773935</pub-id></mixed-citation></ref><ref id="BST-2016-0094C45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sotgia</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Martinez-Outschoorn</surname><given-names>U.E.</given-names></name>, <name name-style="western"><surname>Pavlides</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Howell</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pestell</surname><given-names>R.G.</given-names></name> and <name name-style="western"><surname>Lisanti</surname><given-names>M.P.</given-names></name></person-group> (<year>2011</year>) <article-title>Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment</article-title>. <source>Breast Cancer Res.</source>
<volume>13</volume>, <fpage>213</fpage> doi:<pub-id pub-id-type="doi">10.1186/bcr2892</pub-id><pub-id pub-id-type="pmid">21867571</pub-id></mixed-citation></ref><ref id="BST-2016-0094C46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiler-Sagie</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bushelev</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Epelbaum</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dann</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Haim</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Avivi</surname><given-names>I.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>) <article-title><sup>18</sup>F-FDG avidity in lymphoma readdressed: a study of 766 patients</article-title>. <source>J. Nucl. Med.</source>
<volume>51</volume>, <fpage>25</fpage>&#x02013;<lpage>30</lpage> doi:<pub-id pub-id-type="doi">10.2967/jnumed.109.067892</pub-id><pub-id pub-id-type="pmid">20009002</pub-id></mixed-citation></ref><ref id="BST-2016-0094C47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aldinucci</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Gloghini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pinto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>De Filippi</surname><given-names>R.</given-names></name> and <name name-style="western"><surname>Carbone</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>) <article-title>The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape</article-title>. <source>J. Pathol.</source>
<volume>221</volume>, <fpage>248</fpage>&#x02013;<lpage>263</lpage> doi:<pub-id pub-id-type="doi">10.1002/path.2711</pub-id><pub-id pub-id-type="pmid">20527019</pub-id></mixed-citation></ref><ref id="BST-2016-0094C48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pavlides</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Whitaker-Menezes</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Castello-Cros</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Flomenberg</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Witkiewicz</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Frank</surname><given-names>P.G.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>) <article-title>The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma</article-title>. <source>Cell Cycle</source>
<volume>8</volume>, <fpage>3984</fpage>&#x02013;<lpage>4001</lpage> doi:<pub-id pub-id-type="doi">10.4161/cc.8.23.10238</pub-id><pub-id pub-id-type="pmid">19923890</pub-id></mixed-citation></ref><ref id="BST-2016-0094C49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>D.C.</given-names></name></person-group> (<year>2012</year>) <article-title>Mitochondria and cancer</article-title>. <source>Nat. Rev. Cancer</source>
<volume>12</volume>, <fpage>685</fpage>&#x02013;<lpage>698</lpage> doi:<pub-id pub-id-type="doi">10.1038/nrc3365</pub-id><pub-id pub-id-type="pmid">23001348</pub-id></mixed-citation></ref><ref id="BST-2016-0094C50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Outschoorn</surname><given-names>U.E.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Trimmer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Flomenberg</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pavlides</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>) <article-title>Cancer cells metabolically &#x02018;fertilize&#x02019; the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors</article-title>. <source>Cell Cycle</source>
<volume>10</volume>, <fpage>2504</fpage>&#x02013;<lpage>2520</lpage> doi:<pub-id pub-id-type="doi">10.4161/cc.10.15.16585</pub-id><pub-id pub-id-type="pmid">21778829</pub-id></mixed-citation></ref><ref id="BST-2016-0094C51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitaker-Menezes</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Martinez-Outschoorn</surname><given-names>U.E.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Ertel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Flomenberg</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Witkiewicz</surname><given-names>A.K.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>) <article-title>Evidence for a stromal-epithelial &#x02018;lactate shuttle&#x02019; in human tumors</article-title>. <source>Cell Cycle</source>
<volume>10</volume>, <fpage>1772</fpage>&#x02013;<lpage>1783</lpage> doi:<pub-id pub-id-type="doi">10.4161/cc.10.11.15659</pub-id><pub-id pub-id-type="pmid">21558814</pub-id></mixed-citation></ref><ref id="BST-2016-0094C52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gladden</surname><given-names>L.B.</given-names></name></person-group> (<year>2004</year>) <article-title>Lactate metabolism: a new paradigm for the third millennium</article-title>. <source>J. Physiol.</source>
<volume>558</volume>, <fpage>5</fpage>&#x02013;<lpage>30</lpage> doi:<pub-id pub-id-type="doi">10.1113/jphysiol.2003.058701</pub-id><pub-id pub-id-type="pmid">15131240</pub-id></mixed-citation></ref><ref id="BST-2016-0094C53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodwin</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Gladden</surname><given-names>L.B.</given-names></name>, <name name-style="western"><surname>Nijsten</surname><given-names>M.W.N.</given-names></name> and <name name-style="western"><surname>Jones</surname><given-names>K.B.</given-names></name></person-group> (<year>2015</year>) <article-title>Lactate and cancer: revisiting the Warburg effect in an era of lactate shuttling</article-title>. <source>Front. Nutr.</source>
<volume>1</volume>, <fpage>27</fpage> doi:<pub-id pub-id-type="doi">10.3389/fnut.2014.00027</pub-id><pub-id pub-id-type="pmid">25988127</pub-id></mixed-citation></ref><ref id="BST-2016-0094C54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itoh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Esaki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Shimoji</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Law</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Kaufman</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2003</year>) <article-title>Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>100</volume>, <fpage>4879</fpage>&#x02013;<lpage>4884</lpage> doi:<pub-id pub-id-type="doi">10.1073/pnas.0831078100</pub-id><pub-id pub-id-type="pmid">12668764</pub-id></mixed-citation></ref><ref id="BST-2016-0094C55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>G.J.</given-names></name></person-group> (<year>2015</year>) <article-title>Metabolic reprogramming: the emerging concept and associated therapeutic strategies</article-title>. <source>J. Exp. Clin. Cancer Res.</source>
<volume>34</volume>, <fpage>111</fpage> doi:<pub-id pub-id-type="doi">10.1186/s13046-015-0221-y</pub-id><pub-id pub-id-type="pmid">26445347</pub-id></mixed-citation></ref><ref id="BST-2016-0094C56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Yoon</surname><given-names>J.-H.</given-names></name></person-group> (<year>2015</year>) <article-title>Metabolic interplay between glycolysis and mitochondrial oxidation<underline>:</underline> the reverse Warburg effect and its therapeutic implication</article-title>. <source>World J. Biol. Chem.</source>
<volume>6</volume>, <fpage>148</fpage>&#x02013;<lpage>161</lpage> doi:<pub-id pub-id-type="doi">10.4331/wjbc.v6.i3.148</pub-id><pub-id pub-id-type="pmid">26322173</pub-id></mixed-citation></ref><ref id="BST-2016-0094C57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonveaux</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>V&#x000e9;gran</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Schroeder</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wergin</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Verrax</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rabbani</surname><given-names>Z.N.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>) <article-title>Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice</article-title>. <source>J. Clin. Invest.</source>
<volume>118</volume>, <fpage>3930</fpage>&#x02013;<lpage>3942</lpage> doi:<pub-id pub-id-type="doi">10.1172/JCI36843</pub-id><pub-id pub-id-type="pmid">19033663</pub-id></mixed-citation></ref></ref-list></back></article>